Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-25-001242
Accepted
2025-04-25 00:15:31
Documents
1
Effectiveness Date
2025-04-24

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 589
  Complete submission text file 9999999995-25-001242.txt   1715
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-286662 | Film No.: 25869719
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)